🇺🇸 FDA
Patent

US 10758621

Liquid formulation comprising GM-CSF neutralizing compound

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 10758621 (Liquid formulation comprising GM-CSF neutralizing compound) held by TAKEDA GMBH expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TAKEDA GMBH
Grant date
Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K39/395, A61K39/3955, A61K39/39591